A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine (HCQ) can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether. The study, called Prevention and Treatment of COVID-19 with HCQ (PATCH), is currently enrolling patients in three separate sub-studies (NCT04329923).
PATCH sub-study 1 will evaluate HCQ compared to placebo in infected patients who are quarantined at home. PATCH sub-study 2 will evaluate high dose compared to low dose HCQ in hospitalized patients. PATCH sub-study 3 will evealuate HCQ compared to placebo prophylactically in health care workers working with COVID-19 patients to evaluate whether it can prevent infection. Sub-studies 1 and 3 are double-blind placebo controlled studies, meaning neither the patient nor the doctor will know whether they are taking HCQ or placebo until the end of the study. Importantly, if the patient or health care worker starts getting worse, they can be unblinded, and the trial allows crossover to HCQ if the patient was assigned placebo.
We know HCQ can be an effective anti-viral in a lab setting, but despite recent public conversation, there is no definitive evidence it can work in humans infected with COVID-19. It is our hope that this trial will provide critical evidence as to whether this drug may be effective in combating the current pandemic, said the studys principal investigator Ravi K. Amaravadi, MD, an associate professor of Hematology-Oncology who has spent his career studying HCQ and related compounds.
For this trial, Amaravadi is working with a multidisciplinary team at Penn, including Benjamin S. Abella, MD, MPhil, a professor of Emergency Medicine, and Ian D. Frank, MD, associate chief of Infectious Diseases, as well as colleagues in Pathology and Laboratory Medicine, Cardiology, Statistics, and the Abramson Cancer Center.
The first sub-study of the trial will test HCQ in patients who are infected and are well enough to go home, but who need to be in quarantine. Quarantine can be prolonged for some people who have a worse case of the illness, and can impose significant economic, emotional, and psychological hardship on the patient and his or her family. Family members living with a quarantined COVID-19 patient are at high risk of getting the disease themselves. In order to be released from quarantine, they must meet certain criteria according to the Centers for Disease Control (CDC): patients must go 72 hours without a fever, see their symptoms improve, and go seven days since their symptoms first appeared. The primary goal of PATCH sub-study 1 is to find out whether the drug reduces the number of days the patient stays quarantined. Researchers were forced to overcome unique logistical hurdles, including arranging for virtual consents from patients and home delivery of HCQ doses.
The second sub-study of the trial will test HCQ in patients who are hospitalized with COVID-19 to see if it can reduce the time to discharge. Patients in this group will also be randomized into a high dose or low dose group. No one will receive a placebo. The correct dose of HCQ for treating COVID-19 is not currently known and this study will provide valuable information to answer that question. The third sub-study will test whether HCQ can work as a preventative medicine to stop infection in health care workers at risk of exposure to COVID-19. Researchers plan to enroll 200 workers in the sub-study.
The need for the third sub-study here is critical, as we try to keep the people working on the front lines of this pandemic healthy so they can continue to keep the nations health care infrastructure up and running, Abella said.
Given the rapid spread of the virus, researchers had to work quickly not only to organize the trial and get it approved from a regulatory standpoint, but also to solve practical problems. In the span of less than a month, they were able to secure funding, arrange for a donation of HCQ, and partner with a group to manufacture an appropriate placebo. The researchers say they are grateful to their partners, and also to their leadership for the support that helped it all come together.
This is an unprecedented time, and it will take unprecedented cooperation, resources, and leadership to get through it. This trial shows Penns ability to step up to meet that responsibility and investigate the scientific questions the world desperately needs to answer, said J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine.
Read this article:
Hydroxychloroquine evaluated to treat, prevent COVID-19: University of Pennsylvania trial - Outbreak News Today
- This is Preventive Medicine Toolkit - ACPM - February 15th, 2025
- In a Historic First, Arete Health Partners with InsideTracker to Bring Preventative Health Care as a Covered Benefit for Its Members Turning Sick Care... - February 15th, 2025
- Arkansas kids and tooth decay: Why prevention matters - Jonesboro Sun - February 15th, 2025
- Prevention and a community focus are integral to general practice - The BMJ - February 15th, 2025
- Prenuvo Announces it Had Raised $120M to Advance Preventative Health, Launches Novel FDA-Cleared AI-Powered Products - Business Wire - February 15th, 2025
- What's happening with the anti-HIV program PEPFAR? It depends whom you ask - KNKX Public Radio - February 15th, 2025
- Gender and Healthcare Ownership in Hypertension and Cardiovascular Prevention - Physician's Weekly - February 15th, 2025
- Vaccination Is Key To Disease Prevention - The Tomahawk - February 15th, 2025
- This Louisiana doctor shares timeline of health screenings that could save lives - NOLA.com - February 15th, 2025
- DNA Health & Wellness Brings Advanced Preventative Health and Longevity Solutions to the Capital - PR Newswire - February 15th, 2025
- Preventative healthcare: A wake-up call for India - YourStory - February 15th, 2025
- Could the FDA's recently approved Pap smear alternative reduce racial disparities in cervical cancer deaths? - The Miami Times - February 15th, 2025
- The Promise Of AI In Disease Prediction & Prevention - BW Healthcare World - February 15th, 2025
- AI, Genomics, and Preventive Wellness - Elets - February 15th, 2025
- What is Preventive Medicine? - PMC - PubMed Central (PMC) - January 19th, 2025
- Limited preventive care among Medicaid enrollees with HIV in the US South - Nature.com - January 19th, 2025
- What is the ACAs preventive health services coverage mandate? - Health Insurance Resource Center - January 19th, 2025
- Home and Care Home Health offers fall prevention tips for seniors - Montana Right Now - January 19th, 2025
- What is healthspan, and how can you maximize yours? - American Heart Association News - January 19th, 2025
- MASH Ran For So Long The Showrunners Accidentally Made The Exact Same Episode Twice - Screen Rant - January 19th, 2025
- As the U.S. ages, dementia is on the rise. Here are ways to reduce your risk - WHYY - January 19th, 2025
- The Doctor Is In: Cervical cancer and prevention - Yahoo! Voices - January 19th, 2025
- SCOTUS Takes Up Case Challenging the ACAs No-Cost Coverage of PrEP - Them - January 19th, 2025
- Ounce of Prevention: What is the right time to take my blood pressure medication? - The Manchester Journal - January 19th, 2025
- HMPV: What is it, symptoms, prevention, treatment and more - Health shots - January 19th, 2025
- Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua... - January 19th, 2025
- US Preventive Services Task Force recommends osteoporosis screening for women 65 years and older - Medical Xpress - January 19th, 2025
- 'Preventive healthcare is an unstoppable force' - Longevity.Technology - January 19th, 2025
- Preterm preeclampsia screening and prevention: a comprehensive approach to implementation in a real-world setting - BMC Pregnancy and Childbirth - January 19th, 2025
- ABC-7 at 4: Healthcare 2025 and Beyond - NewsBreak - January 19th, 2025
- HMPV is spreading in India: 9 tips to prevent the infection - Health shots - January 19th, 2025
- How to Identify and Prevent Frostbite - A Healthier Michigan - December 28th, 2024
- Preventive care with Nutrition key to overcome heightened disease burden in India: Experts - ETHealthWorld - December 28th, 2024
- UNM researcher is advancing HIV Prevention and Health Equity for Native Americans - Albuquerque Journal - November 16th, 2024
- CVS Health expands access to primary care services at select MinuteClinic locations - CVS Health - November 16th, 2024
- Decrease in syphilis diagnoses among gay men most likely linked to preventive antibiotic use - NBC News - November 16th, 2024
- Breakthrough T1D Leads Effort to Make Screening for T1D Part of Recommended Preventive Services in the US - cnhinews.com - November 16th, 2024
- Pakistan Has The Worlds Highest Diabetes Prevalence - And Lacks Focus On Prevention - Health Policy Watch - November 16th, 2024
- Herbal medicine shows great potential in treating and preventing dementia - Earth.com - November 16th, 2024
- Health and Wellness Market to Grow by USD 1.93 Trillion (2024-2028), Driven by Rising Focus on Health Programs, AI-Powered Report Highlights Market... - November 16th, 2024
- Care for body and mind. And important prevention. - KODA Storyboard - November 16th, 2024
- The 8th World Integrative Medicine Congress - Preventive Care as a Priority, Universal Health for All - openPR - November 16th, 2024
- World Pneumonia Day 2024: 6 symptoms of pneumonia in the elderly - Health shots - November 16th, 2024
- Mercks Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence... - October 22nd, 2024
- New Strategies to Extend the HIV Treatment Cascade for CVD Prevention - Infectious Disease Special Edition - October 22nd, 2024
- Shea fights breast cancer with family support - nwestiowa.com - October 22nd, 2024
- Cancer hospitals' cancer prevention plansand what's foiling them - Newsweek - October 22nd, 2024
- The Wright Medicine: Breast Cancer Awareness Month a time to tout preventive measures - Valley Advantage - October 22nd, 2024
- Prevention and Management of Urolithiasis With Parsley and Barley Among the Hail Population, Saudi Arabia: Is It Fact or Not? - Cureus - October 22nd, 2024
- Leveraging Patient Data for Early Healthcare Interventions: Insights from Gerard Hanratty of Browne Jacobson - Healthcare Digital - October 22nd, 2024
- Why Wes Streetings prevention agenda is sinister - The Spectator - October 22nd, 2024
- An injectable HIV-prevention drug is highly effective but wildly expensive - NBC News - September 13th, 2024
- Top preventive health tips your internist wants you to know - American Medical Association - September 13th, 2024
- National Falls Prevention Week: Turning awareness into action - McKnight's Long-Term Care News - September 13th, 2024
- UToledo Health Mobile Clinic Takes Preventative Care on the Road - UToledo News - September 13th, 2024
- Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? - The Mercury - Manhattan, Kansas - September 13th, 2024
- Von der Leyen to ramp up EU healthcare union and focus on preventative treatment - MedWatch - September 13th, 2024
- Kate Middleton's preventative chemotherapy explained: The gruelling drugs that are proven to stop disease retu - Daily Mail - September 13th, 2024
- Personalised prevention in England - The Health Foundation - September 13th, 2024
- Stay on top of your fur baby's health: the importance of scheduling routine vet visits - FoxReno.com - May 17th, 2023
- Preventive healthcare - May 9th, 2023
- What Is Preventive Health and Why Is It Important? - May 9th, 2023
- What Is Preventive Medicine & Why Do We Need It? | AUC - February 16th, 2023
- Preventive Medicine | Journal | ScienceDirect.com by Elsevier - December 3rd, 2022
- Migraine - Diagnosis and treatment - Mayo Clinic - December 3rd, 2022
- Functional Medicine of Idaho | Preventative Root Cause Medicine - December 3rd, 2022
- These 2 Staten Island nurses believe IV hydration drips and vitamin shots are key to long-term health - SILive.com - December 3rd, 2022
- CNBCTV-18 and IIM-K's India@2047 Leadership Series: Challenges and opportunities in the fintech and healthcare sectors - Forbes India - December 3rd, 2022
- As N.W.T. mulls health coverage changes, petition calls for preventative HIV drug to be free - CBC.ca - September 20th, 2022
- EU regulator backs wider use of AstraZeneca COVID therapy - Reuters - September 20th, 2022
- Choose integrative medicine for health and wellness - Technique - September 20th, 2022
- The high hospital bills we make victims of rape and sexual violence pay - Vox.com - September 20th, 2022
- 4 Anti-Aging Products Youre Using All Wrong, According To Skincare Experts - SheFinds - September 20th, 2022
- Why Now is the Time to Double Down on Virtual Care - HIT Consultant - September 20th, 2022
- Tell Giselle: The price of good help is priceless - Wilkes Barre Times-Leader - September 20th, 2022
- Heron Therapeutics Announces U.S. FDA Approval of APONVIE (HTX-019) for the Prevention of Postoperative Nausea and Vomiting (PONV) - BioSpace - September 20th, 2022
- Pickleball injuries are on the rise: 5 preventive tips to keep you on the court - The Manual - September 20th, 2022
- The next big social movement and other takeaways from our regular meeting - POLITICO - September 20th, 2022
- 15 Mushrooms and How to Use Them in Vegan Cooking - VegNews - September 20th, 2022
- Use of honey in the management of Chemotherapy | CMAR - Dove Medical Press - September 20th, 2022